Applying the non-maleficence principle to basic research in Alzheimer's disease

Area of Science:

• Neuroscience
• Biomedical Research Ethics

Background:

• Alzheimer's disease (AD) interventions urgently require new research leads.
• The socioeconomic impact of basic AD research is often considered distant.
• Ethical stringency is paramount in fundamental AD research.

Purpose of the Study:

• To emphasize the critical importance of ethical stringency and reproducibility in basic Alzheimer's disease research.
• To advocate for the principle of non-maleficence in biomedical research, prioritizing it over unsubstantiated claims.

Main Methods:

• This study is a conceptual analysis and ethical argument.
• It reviews the potential consequences of unreliable research findings in AD.

Main Results:

• Unreliable or irreproducible basic research can falsely raise hopes and misdirect future scientific endeavors.
• Research misconduct or lack of rigor can prematurely terminate promising research avenues.

Conclusions:

• The principle of non-maleficence, focusing on avoiding harm, should guide biomedical research practices.
• Prioritizing rigor and reproducibility over premature or hyped claims is essential for responsible AD research and patient welfare.